Find tour dates and live music events for all your favorite bands and artists in your city! Get concert tickets, news and more!

  • Analytics
  • Tour Dates

Clear Channel Sued For Concert Ticket Price Fixing

CHICAGO (CelebrityAccess Mediawire)– Wexler Toriseva Wallace LLP, Co-Lead Counsel for Plaintiffs, announced that Judge Stephen V. Wilson in the United States District Court for the Central District of California in Los Angeles has issued a 136-page opinion certifying a class of ticket buyers to Clear Channel rock concerts and denying Clear Channel's motion for judgment on the pleadings. Plaintiffs allege that Clear Channel monopolized the market for tickets to rock concerts and therefore caused those ticket buyers to pay more for their tickets to Clear Channel's rock concerts.

The Court's order certifies classes of ticket buyers in Los Angeles, Chicago, Boston, New York and Denver. These five regional markets were used as "template" markets during the class certification stage. Plaintiffs have filed cases against Clear Channel in 23 different regional markets, all of which have been consolidated before Judge Wilson in Los Angeles. The Court's order denying Defendants' motion for judgment on the pleadings refused to dismiss Plaintiffs' attempted monopolization claim at this stage of the case.

Wexler Toriseva Wallace LLP is a national leader in major class action and mass tort litigation. The firm has been instrumental in providing meaningful relief for thousands of consumers, small businesses, large corporations and health and welfare funds in litigation throughout the United States. Among the cases in which WTW is currently acting as co-lead counsel are a nationwide class action against numerous drug manufacturers challenging their publication if fraudulent Average Wholesale Prices, a nationwide action seeking recovery on behalf of individuals who have had defective versions of the Composix Kugel Mesh Patches implanted, and a class action on behalf of consumers and third party payors regarding an illegal scheme by wholesaler giant McKesson Corporation and publisher First DataBank that caused billions of dollars in overcharges for brand-name pharmaceutical drugs. — (CelebrityAccess Staff Writers)